Gilead Sciences Inc. Canadian Depositary Receipt (GILD)
TSX
30.43
+0.84 (+2.84%)
Closed
Oct 9, 2026
Day's Range
30.1730.44
52 wk Range
23.9731.80
Financial Statements - GILD - Gilead Sciences Inc. Canadian Depositary Receipt
Revenue
29.44B▼ 25.1%
Net Income
8.51B▲ 1196.7%Net Margin 28.9%
EBITDA
14.80B▼ 20.1%
Free Cash Flow
9.45B▼ 32.9%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Sales | 29.44B | 39.31B |
| Cost of Goods | 6.23B | 8.54B |
| Gross Profit | 23.20B | 30.76B |
 Operating Expense | - | - |
| Operating Income | 11.70B | 14.36B |
| Non-Operating Interest | - | - |
| Other Income Expense | -1.23B | -12.46B |
| Pre Tax Income | 9.79B | 943.37M |
| Income Tax | 1.28B | 288.48M |
| Net Income | 8.51B | 656.26M |
| EPS Basic | 1.026722 | 0.05704 |
| EPS Diluted | 1.017716 | 0.05704 |
| Basic Shares Outstanding | 8.28B | 11.35B |
| Diluted Shares Outstanding | 8.28B | 11.35B |
| Ebit | 10.82B | 2.27B |
| Ebitda | 14.80B | 18.52B |
| Net Income Continuous Operations | 8.51B | 656.26M |
| Minority Interests | 0 | 0 |
| Preferred Stock Dividends | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
